[Insightec in Business Wire] SonALAsense forges forward with first affected person dosing for devastating childhood mind most cancers

OAKLAND, Calif.–(BUSINESS WIRE)–Diffuse intrinsic pontine glioma (DIPG) is a uncommon and lethal pediatric mind most cancers with a 2% five-year survival price. To supply therapeutic choices for sufferers and households, SonALAsense is partnering with clinicians at Kids’s Nationwide Hospital, Ivy Mind Tumor Heart at Barrow Neurological Institute, Phoenix Kids’s Hospital and College of California San Francisco (UCSF) Medical Heart to conduct a section 1/2 scientific trial for sonodynamic remedy (SDT). That is the primary SDT trial for youngsters.

Learn extra right here.